Dr. Athiya Agarwal has formally disclosed the acquisition of shares in Dr. Agarwal’s Health Care Limited via an inter-se transfer of shares between promoters, executed as a gift. The acquisition, finalized on March 19, 2026, increased Dr. Athiya Agarwal’s holding to 1,41,03,543 shares, representing 4.45% of the total share capital. The transferor was Dr. Anosh Agarwal, with no change to the total equity capital of the company.
Disclosure of Shareholding Change
This filing serves as the mandatory disclosure regarding a change in shareholding involving the promoter group of Dr. Agarwal’s Health Care Limited. The transaction involved Dr. Athiya Agarwal acquiring shares from Dr. Anosh Agarwal through an inter-se transfer executed by way of gift.
Shareholding Position Before Transfer
Prior to the acquisition under consideration, Dr. Athiya Agarwal held the following stake in the Target Company (TC):
- Shares carrying voting rights: 1,26,61,975, which accounted for 4.00% of the total share capital.
- The total holding (including encumbrances, warrants, etc.) stood at 1,26,61,975 shares (4.00%).
Details of Acquisition/Sale
The details of the transaction executed on March 19, 2026, are as follows:
- Shares carrying voting rights acquired/sold: 14,41,568 shares.
- This constituted 0.455% of the total voting capital.
- The total transaction volume was 14,41,568 shares (0.455%).
- The Mode of acquisition / sale was specified as Inter-se off market transfer of shares between promoter / promoter group by way of gift.
Shareholding Position After Transfer
Following the completion of this inter-se transfer, Dr. Athiya Agarwal’s resulting shareholding is:
- Shares carrying voting rights: 1,41,03,543 shares.
- This new holding represents 4.45% of the total share capital, both on a current and diluted basis.
Company Capital Structure
The filing confirms that the equity share capital structure of Dr. Agarwal’s Health Care Limited remained unchanged throughout the process:
- Equity share capital before and after the said acquisition / sale: 31,68,07,506 equity shares of Re. 1/- each, aggregating to Rs. 31,68,07,506.
- The Total diluted share/voting capital of the TC after the acquisition also stands at 31,68,07,506 shares.
Source: BSE
